The Accelerator Grants: Migraine Research program aims to support bold, innovative research that has the potential to drive new insights and improve prevention, diagnosis, and treatment strategies for migraine.
The program will support research that advances our understanding of the causes, risk factors, and symptoms of migraine, including, but not limited to, the biological underpinnings of the condition; the identification of biomarkers to enhance prevention, diagnosis, and treatment management; and the development and testing of novel therapies or interventions. Projects must consider the influence of sexand gender-related factors in the design, analysis, and evaluation of the research given the disproportionate impact of migraine on women.
It is anticipated that this funding will catalyze new insights and support the generation of preliminary data, tools, or interventions that can inform and enable new directions in the field.
Grant Details
The Accelerator Grants: Migraine Research program has an overall funding envelope of $480,000 CAD to support up to three grants of $160,000 each over three years. Grants are non-renewable.
Equity, Diversity, and Inclusion
Evidence clearly shows that increasing equity, diversity and inclusion in research environments enhances excellence, innovation and creativity. We are committed to excellence through equity and encourage applicants of diverse backgrounds to apply to our funding opportunities, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.
Use of Funds Funds must contribute toward the direct costs of the research project for which they were awarded and should be directly attributable to the project or activity being performed. Funds can only be disbursed and used within Canada. Exceptions may be considered on a case-by-case basis with clear justification and prior approval from Brain Canada.
1. Strong neuroscience relevance
The most competitive applications directly address:
Projects clearly advancing brain science are strongly favored.
2. Transformative and innovative science
Brain Canada strongly prioritizes:
Innovation is one of the strongest predictors of competitiveness.
3. Strong translational or clinical impact
Successful proposals often demonstrate potential to:
Applications connecting discovery science with patient benefit tend to perform especially well.
4. Interdisciplinary collaboration
High-scoring projects frequently involve:
Cross-disciplinary integration is heavily valued.
5. Strong methodological rigor
Competitive proposals generally demonstrate:
Weak methodology is a major reviewer concern.
6. Strong preliminary data
Applications with:
typically receive stronger reviewer confidence.
7. Team science and collaborative networks
Brain Canada strongly favors:
Large collaborative ecosystems are highly competitive.
8. Equity, diversity, and inclusion (EDI)
Brain Canada increasingly prioritizes:
Meaningful EDI integration strengthens applications.
9. Strong investigator track record
Important predictors include:
For early-career programs, trajectory and future potential are heavily considered.
10. Potential for long-term impact and scalability
Reviewers favor projects likely to:
This opportunity supports multidisciplinary teams that bring together the expertise required to address this complex neurological condition. Where appropriate, applicants are encouraged to meaningfully engage people with lived experience to ensure that research priorities, design, and outcomes reflect realworld needs and perspectives.
• Teams must include a minimum of two independent investigators, as described below, with one designated as the Principal Investigator.
• Investigators must be conducting research at, and affiliated with, an eligible Canadian academic institution for the entire duration of the grant and must be considered a full-time independent researcher at their institution. Such an individual normally holds the rank of assistant, associate, or full professor; can initiate and direct their own independent lines of research as principal investigator; has full responsibility for running their laboratories; has full control of their research funds; and is permitted to supervise trainees, if applicable, as per their institution’s policy. Academic appointments must have started by the deadline for Full Application submission. Postdoctoral fellows, research associates, and adjunct faculty are not eligible to apply.
• Teams may include additional members and collaborators, as needed, to ensure the required expertise is present to carry out the proposed research.
• Proposals may be related but cannot be identical to any other funded projects. It is the responsibility of the applicants to notify Brain Canada immediately should overlap arise from funding awarded during the application and review process of this funding opportunity. Overlap is defined as having the same objectives and/or experimental aims as any other funded work.
• Applicants can only submit one application as Principal Investigator.
• Applicants must submit a Registration Form to be eligible to submit a Full Application.
• Applicants must be able to initiate the project in February 2027, when funding is expected to begin.
Sponsor Institute/Organizations: Brain Canada
Sponsor Type: Corporate/Non-Profit
Address: 1200 McGill College Avenue Suite 1600, Montreal, Quebec H3B 4G7
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 03, 2026
$116,800
Affiliation: Brain Canada
Address: 1200 McGill College Avenue Suite 1600, Montreal, Quebec H3B 4G7
Website URL: https://braincanada.ca/files/accelerator-grants-migraine-research-2026-rfa.pdf
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.